Peter Stirling

Dr. Peter Stirling leads the Stirling lab embedded within the Terry Fox Laboratory at the BC Cancer Agency. His lab is using functional genomics, molecular biology, biochemistry, and imaging in yeast, C. elegans, and human cells to study fundamental mechanisms of genome maintenance and stability. Failure to maintain genome integrity leads to mutations that can promote tumour formation. Normal genome maintenance mechanisms can be overwhelmed by carcinogen exposure, or the presence of germline or somatic variants that induce genomic instability.

The work of Dr. Stirling’s lab is aimed at determining the causes of genomic instability as an enabling characteristic of tumour formation and exploring the potential of these early events to suggest novel therapeutic targets.

An up-to-date list of publications by Dr. Stirling is available here.